Obicetrapib lowers LDL-C in patients on high intensity statins: Results from the rose trial (NCT04753606)

Autor: Ray, K.K., Nicholls, S., Ditmarsch, M., Kastelein, J.J., Rigby, S., Kling, D., Curcio, D., Alp, N., Davidson, M.
Zdroj: In Atherosclerosis August 2022 355
Databáze: ScienceDirect